AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

INSPIRATION HEALTHCARE GROUP PLC

Director's Dealing Sep 24, 2019

7711_dirs_2019-09-24_b0b32df8-3e5e-45e8-b351-859476f4ce2c.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4502N

Inspiration Healthcare Group PLC

24 September 2019

24 September 2019

Inspiration Healthcare Group plc

("Inspiration Healthcare" or the "Company")

Director/PDMR Shareholding

Further to the Company's announcements on 5 September 2019 and 23 September 2019, Inspiration Healthcare announces that certain Directors have, following Admission today, acquired a total of 154,693 ordinary shares of 10 pence each in the Company ("Ordinary Shares") via the Placing as detailed below:

Name Number of Placing Shares subscribed for Value of Placing Shares subscribed for Resultant shareholding following subscription in the Placing Percentage of enlarged share capital following proposed subscription
Mark Abrahams Non-executive Chairman 86,047 £49,907.26 241,201 0.6%
Mike Briant Chief Financial Officer 34,323 £19,907.34 34,323 0.1%
Brook Nolson Non-executive Director 34,323 £19,907.34 34,323 0.1%
Total 154,693 £89,721.94 309,847 0.8%

Unless otherwise defined herein, capitalised terms used in this announcement shall have the same meanings as defined in the circular sent to shareholders of the Company on 5 September 2019.

The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1.   Mark Abrahams

2.   Mike Briant

3.   Brook Nolson 

2

Reason for the notification

a)

Position/status

1.   Non-executive Chairman

2.   Chief Financial Officer

3.   Non-executive Director

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Inspiration Healthcare Group plc

b)

LEI

213800GKFT3ENAPMDL15

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 10 pence each

ISIN: GB00BXDZL105

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price(s) Volume(s)
1.   58 pence

2.   58 pence

3.   58 pence
1.   86,047

2.   34,323

3.   34,323

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

24 September 2019

f)

Place of the transaction

London Stock Exchange, XLON

Enquiries:

Inspiration Healthcare Group plc

Neil Campbell, Chief Executive Officer

Mike Briant, Chief Financial Officer
Tel: 01455 840555
Cenkos Securities plc - Nominated Adviser & Broker

Stephen Keys / Cameron MacRitchie
Tel: 0207 397 8900
Cadogan PR

Alex Walters

[email protected]
Tel: 07771 713608

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies. 

Through investment in research and development the Company has 6 key own brand products that can be used within the first 6 hours of life to help premature and sick babies; helping with assessment, resuscitation, stabilisation as well as preventing brain damage. Additionally the Company has its own range of products for maintaining normothermia pre- during and post-surgery.

With product availability extending to over 50 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.

In the UK and Ireland the Company has a direct sales team selling Inspiration Branded and complementary products from third parties, with an additional range of home healthcare products.  This is supported by Technical Support for planned preventative maintenance and emergency assistance.

Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHLIFIAADISFIA

Talk to a Data Expert

Have a question? We'll get back to you promptly.